Search

Search Constraints

You searched for: Author/Creator Cleary, James M.

Search Results

1. A phase 2 and biomarker study of cabozantinib in patients with advanced cholangiocarcinoma. Issue 11 (13th February 2017)

2. ALK Inhibitors in Patients With ALK Fusion–Positive GI Cancers: An International Data Set and a Molecular Case Series. (27th April 2022)

3. FOLFOX plus ziv‐aflibercept or placebo in first‐line metastatic esophagogastric adenocarcinoma: A double‐blind, randomized, multicenter phase 2 trial. Issue 13 (26th March 2019)

4. Phase II and Pharmacodynamic Study of Autophagy Inhibition Using Hydroxychloroquine in Patients With Metastatic Pancreatic Adenocarcinoma. (12th May 2014)

5. Preemptive Versus Reactive Topical Clobetasol for Regorafenib-Induced Hand-Foot Reactions: A Preplanned Analysis of the ReDOS Trial. (6th March 2021)

6. Preemptive Versus Reactive Topical Clobetasol for Regorafenib‐Induced Hand‐Foot Reactions: A Preplanned Analysis of the ReDOS Trial. (6th March 2021)